Skip to main content
PLOS One logoLink to PLOS One
. 2020 Dec 9;15(12):e0243373. doi: 10.1371/journal.pone.0243373

Characteristics and related factors of emergency department visits, readmission, and hospital transfers of inpatients under a DRG-based payment system: A nationwide cohort study

Pei-Fang Huang 1,2, Pei-Tseng Kung 3,4,#, Wen-Yu Chou 1, Wen-Chen Tsai 1,*,#
Editor: Giuseppe Remuzzi5
PMCID: PMC7725315  PMID: 33296413

Abstract

Objectives

Taiwan has implemented the Diagnosis Related Groups (DRGs) since 2010, and the quality of care under the DRG-Based Payment System is concerned. This study aimed to examine the characteristics, related factors, and time distribution of emergency department (ED) visits, readmission, and hospital transfers of inpatients under the DRG-Based Payment System for each Major Diagnostic Category (MDC).

Methods

We conducted a retrospective cohort study using data from the National Health Insurance Research Database (NHIRD) from 2012 to 2013 in Taiwan. Multilevel logistic regression analysis was used to examine the factors related to ED visits, readmissions, and hospital transfers of patients under the DRG-Based Payment System.

Results

In this study, 103,779 inpatients were under the DRG-Based Payment System. Among these inpatients, 4.66% visited the ED within 14 days after their discharge. The factors associated with the increased risk of ED visits within 14 days included age, lower monthly salary, urbanization of residence area, comorbidity index, MDCs, and hospital ownership (p < 0.05). In terms of MDCs, Diseases and Disorders of the Kidney and Urinary Tract (MDC11) conferred the highest risk of ED visits within 14 days (OR = 4.95, 95% CI: 2.69–9.10). Of the inpatients, 6.97% were readmitted within 30 days. The factors associated with the increased risk of readmission included gender, age, lower monthly salary, comorbidity index, MDCs, and hospital ownership (p < 0.05). In terms of MDCs, the inpatients with Pregnancy, Childbirth and the Puerperium (MDC14) had the highest risk of readmission within 30 days (OR = 20.43, 95% CI: 13.32–31.34). Among the inpatients readmitted within 30 days, 75.05% of them were readmitted within 14 days. Only 0.16% of the inpatients were transferred to other hospitals.

Conclusion

The study shows a significant correlation between Major Diagnostic Categories in surgery and ED visits, readmission, and hospital transfers. The results suggested that the main reasons for the high risk may need further investigation for MDCs in ED visits, readmissions, and hospital transfers.

1. Introduction

Many countries have successfully implemented Prospective Payment Systems (PPSs) to increase hospitals' efficiency in treating patients. The Diagnosis Related Groups (DRGs) belong to the PPS. In 1983, this system was officially adopted by the US Medicare [1], with many countries following suit [2].

After implementing DRG-based payment systems in the USA, Germany, Korea, and other countries, the average length of hospitalization was significantly reduced [36]. Some studies have analyzed this based on specific or common surgical cases, and the results showed that healthcare quality either improved or showed no significant change after system implementation [79]. In addition to the common measure of "length of hospitalization," healthcare quality indicators also include the post-discharge readmission rate (such as ED visits and readmission rate), hospital transfer rate, and intensity of care (i.e., the number of orders during one’s hospitalization) [79]. Although DRG-based payment systems are widely used, they still have some hidden problems. Studies suggest that hospitals may discharge patients earlier due to cost considerations, which could adversely impact healthcare quality [10]. Many studies showed that there is a reduction in healthcare quality, such as earlier hospital discharge, increased readmission, and unsatisfactory patient care [1115].

Since 2010, Taiwan has implemented the National Health Insurance Taiwanese Diagnosis Related Groups (Tw-DRG) payment system in stages. In this system, there is a fixed hospitalization payment by the National Health Insurance to the medical institutions that are estimated based on the medical costs of previous identical or similar diseases. From January 2010 to June 2014, the first stage of this system was implemented in 164 Major Diagnostic Categories (MDCs). After the system was implemented, the average LOS decreased. There was an increase in 3-day ED visits and a 14-day readmission rate initially in 2010, which, however, declined in 2011 when the NHI administration took charge [16]. Whether the decline in ED visits and readmission rates is a result of strict control procedures described in the literature [11, 12], which may in turn increase readmission rates, or are due to delayed ED visits and readmissions to avoid indicator monitoring intentionally. Previous studies showed that possible factors for readmission and ED visits of patients include gender, age, socioeconomic status, and comorbidity [1721]. Some DRG-related patients might be transferred to other hospitals due to cost-saving issues or other reasons. Previous studies showed that hospital transfer of critically ill patients might put patients at high risk [22], and factors that cause hospital transfers include gender, age, and comorbidity [2325].

Many studies demonstrate that healthcare behavior is also a research emphasis in addition to healthcare quality, and they unanimously state that system implementation will cause changes in healthcare behavior [7, 2628]. These changes may also include adverse effects. Previously, studies found that DRG-based payment systems induce morally questionable practices such as upcoding and cream-skimming, which causes an increase in the number of readmitted patients and patient selection [5, 2933]. Concerning the effects of DRG-based payment systems on medical costs in various countries, most studies showed that total medical cost increased after system implementation [9, 3436].

Most existing studies on DRG-based payment systems have analyzed specific diseases or their scope [9, 14]. Few studies examined the ED visits and readmission of patients in a variety of MDCs under DRG-based payment systems. Therefore, this study examines 12 MDCs in the DRG-based payment system in Taiwan from 2012 and 2013 to comprehensively analyze the distribution status and relevant factors of ED visits and readmissions of patients and the characteristics of inpatients who transferred to other hospitals and the relevant factors.

2. Methods

2.1. Data source and participants

This study is a retrospective cohort study. The data were obtained from the National Health Insurance Research Database (NHIRD) released by the National Health Research Institutes from 2012 to 2013. Inpatients in the DRG-based payment system from 1 January 2012 to 30 November 2013 were the subjects of this study, and 12 MDCs were included: MDC2, MDC3, MDC5, MDC6, MDC7, MDC8, MDC9, MDC10, MDC11, MDC12, MDC13, and MDC14. These 12 MDCs concern surgical conditions. In order to avoid subject dependence, only the first DRG hospitalization of every subject during the range of the study period was included, and data from the second hospitalization onwards were not included. It means that every sample has one set of hospitalization data within the range of the study period.

This study is mainly organized into three sections: ED visits, readmissions, and hospital transfers of inpatients under the DRG-based payment system. The first section of the analysis examined whether inpatients visited the ED within 14 days after discharge and examined the time distribution of ED visits. The second section of the analysis examined readmitted patients using 30 days after discharge as the observation period. Patients were divided into two populations depending on whether they were readmitted or not. Besides, the time distribution of readmissions of patients who were readmitted within 30 days after discharge was examined. The third section of the analysis examined hospital transfer inpatients, and the parental population was divided for comparison based on whether hospital transfers occurred.

As our study examined 30-day readmission, subjects from 1 January 2012 to 30 November 2013 were included, and subjects who were discharged after 1 December 2013 (including on that day) were excluded (n = 4,328). Our study also excluded patients who sought consultation at EDs in clinics (n = 5) and patients with missing data (n = 359).

2.2. Description of variables

In this study, the dependent variables included (1) Whether the patient visited the ED within 14 days after discharge; (2) Whether patients were readmitted within 30 days after discharge; (3) Whether hospitalized patients were transferred to other hospitals for treatment.

Independent variables included (1) patient demographic characteristics (i.e., gender, age), economic factor (i.e., monthly salary), health status (i.e., Charlson Comorbidity Index, CCI), disease diagnosis status (i.e., Major Diagnostic Categories, MDCs), emergency department triage scale, route of hospitalization (i.e., whether through the emergency department or not), and whether diagnoses were same as previous ones; (2) inpatient hospital characteristics (i.e., hospital accreditation level, hospital ownership, number of hospital beds); and (3) environmental factors (i.e., degree of urbanization of residence area, degree of urbanization of the hospital’s location).

The particular variables are described as follows: (1) The economic status of patients was measured using a monthly salary. In this study, monthly salary was classified into the ranges of ≤ 17,880 NTD (New Taiwan Dollar), 17,881––22,800 NTD, 22,801–28,800 NTD, 28,801–36,300 NTD, 36,301–45,800 NTD, 45,801–57,800 NTD, and ≥ 57,801 NTD. (2) For environmental factors, the level of urbanization of the place of residence was used. It was divided into Levels 1 to 7, with Level 1, the highest, and Level 7 the lowest [37]. (3) The severity of comorbidities in patients was measured using Deyo’s Charlson Comorbidity Index (CCI) modified and developed by Deyo et al. [38]. The primary diagnosis code for diseases was converted to weighted scores that were totaled to obtain the Deyo’s CCI score. In this study, the scores were divided into ranges of 0, 1, 2, and ≥ 3. (4) MDCs were the 12 categories in the DRG-based payment system from 2012 to 2013, which were: MDC2: Diseases and Disorders of the Eye, MDC3: Diseases and Disorders of the Ear, Nose, Mouth, and Throat, MDC5: Diseases and Disorders of the Circulatory System, MDC6: Diseases and Disorders of the Digestive System, MDC7: Diseases and Disorders of the Hepatobiliary System and Pancreas, MDC8: Diseases and Disorders of the Musculoskeletal System and Connective Tissue, MDC9: Diseases and Disorders of the Skin, Subcutaneous Tissue, and Breast, MDC10: Endocrine, Nutritional, and Metabolic Diseases and Disorders, MDC11: Diseases and Disorders of the Kidney and Urinary Tract, MDC12: Diseases and Disorders of the Male Reproductive System, MDC13: Diseases and Disorders of the Female Reproductive System, and MDC14: Pregnancy, Childbirth, and the Puerperium. Whether patients had the same diagnosis was determined based on the International Disease Classification Code (ICD-9-CM) diagnosis. The primary and secondary diagnoses during ED visits or readmissions were compared to see if they were identical to the primary diagnosis from the previous hospitalization stay. The emergency treatment triage scale used was the five-level Taiwan Triage and Acuity Scale released by the Ministry of Health and Welfare, with Level 1 being resuscitation, Level 2 emergency, Level 3 urgent, Level 4 less urgent, and Level 5 non-urgent [39]. (5) For inpatient hospital characteristics, hospitals were divided by accreditation level into medical centers, regional hospitals, and district hospitals. For hospital ownership, hospitals were divided into public and non-public hospitals. Hospital bed scores were divided into groups of ≤ 300 beds, 301–600 beds, 601–1000 beds, 1001–1500 beds, and ≥1501 beds.

2.3. Statistical analysis

Descriptive statistics were used to analyze ED visits within 14 days after discharge, the time distribution of 30-day readmissions, and whether patients were transferred to another hospital during hospitalization under the DRG-based payment system from 2012 to 2013. Independent variables were defined as described above in the description of variables.

Multilevel logistic regression was used to test the correlation between “ED visits within 14 days after discharge,” “readmission within 30 days,” and “hospital transfers” of inpatients under the DRG-based payment system with variables, including (1) individual-level such as patient characteristics, economic status, health status, disease diagnosis status, and route of hospitalization; (2) hospital-level such as hospital characteristics; (3) regional level such as environmental factors. SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) statistics software was used for data processing and statistical analysis. A difference of p < 0.05 was considered to be statistically significant. In this study, all personal identification information was deleted, and personal privacy was protected during the use of these data. The research ethics committee approved this study at China Medical University and Hospital (IRB Number: CMU-REC-101-012).

3. Results

From 2012 to 2013, a total of 103,779 inpatients under the DRG-based payment system were included as study subjects (Table 1), with females accounting for most of the patients (66.72%). Most patients were from the age group of 19–44 years (49.39%) and had a CCI score of 0 (68.9%). In terms of MDCs, most patients (30.02%) had a diagnosis of Pregnancy, Childbirth, and the Puerperium (MDC14), followed by patients (25.4%) with Diseases and Disorders of the Musculoskeletal System and Connective Tissue (MDC8). Concerning the hospital accreditation level, most patients were admitted to regional hospitals (43.41%). About hospital ownership, most patients were admitted to non-public hospitals (76.76%).

Table 1. Baseline DRGs patient characteristics.

Variable N % Variable N %
Total 103,779 100.00 MDC3 4,294 4.14
gender MDC5 8,942 8.62
    female 69,240 66.72 MDC6 15,285 14.73
    male 34,539 33.28 MDC7 3,672 3.54
age (year) MDC8 26,365 25.40
    ≤18 2,456 2.37 MDC9 395 0.38
    19–44 51,261 49.39 MDC11 129 0.12
    45–64 26,531 25.56 MDC12 1,500 1.45
    ≥65 23,531 22.67 MDC13 9,019 8.69
monthly salary (NTD) MDC14 31,158 30.02
    ≤17,280 1,468 1.41 hospital accreditation level
    17,281–22,800 41,238 39.74 medical center 35,568 34.27
    22,801–28,800 20,467 19.72 regional hospital 45,055 43.41
    28,801–36,300 15,681 15.11 district hospital 23,156 22.31
    36,301–45,800 11,276 10.87 hospital ownership
    45,801–57,800 6,078 5.86 public hospital 24,119 23.24
    ≥57,801 7,571 7.30 non-public hospital 79,660 76.76
Charlson Comorbidity Index (CCI) urbanization of residence area
    0 71,506 68.90 Level 1 29,712 28.63
    1 16,289 15.70 Level 2 34,272 33.02
    2 8,005 7.71 Level 3 16,382 15.79
    ≥3 7,979 7.69 Level 4 14,008 13.50
Major Diagnostic Category(MDC) Level 5 1,881 1.81
    MDC10 1,878 1.81 Level 6 3,749 3.61
    MDC2 1,142 1.10 Level 7 3,775 3.64

Note: The hospital is the hospital that DRGs patient discharged from.

For ED visits, we can see from Table 2 that 4,831 inpatients had ED visits within 14 days (accounting for 4.66%). Among these ED patients, 8.76% had the same primary and secondary diagnoses as on the previous hospitalization. From the bivariate analysis results in Table 2, we can see that factors, including gender, age, monthly salary, degree of urbanization of residence area, CCI, MDCs, hospital accreditation level, and hospital ownership, showed a significant correlation with ED visits within 14 days after discharge (p < 0.05).

Table 2. Bivariate and multilevel regression analysis of DRGs patients’ emergency department visits within 14 days after discharge.

Variable No Yes P value Adjusted OR 95%CI P value
N % N %
Total 98,948 95.34 4,831 4.66
gender <0.001
    female (ref.) 66,235 95.66 3,005 4.34 1.00
    male 32,713 94.71 1,826 5.29 1.00 0.93 1.08 0.952
age (year) <0.001
    ≤18 (ref.) 2,369 96.46 87 3.54 1.00
    19–44 49,155 95.89 2,106 4.11 1.15 0.92 1.44 0.228
    45–64 25,515 96.17 1,016 3.83 0.98 0.78 1.23 0.871
    ≥65 21,909 93.11 1,622 6.89 1.42 1.12 1.78 0.003
monthly salary (NTD) <0.001
    ≤17,280(ref.) 1,342 91.42 126 8.58 1.00
    17,281–22,800 39,368 95.47 1,870 4.53 0.51 0.42 0.62 <0.001
    22,801–28,800 19,446 95.01 1,021 4.99 0.59 0.48 0.71 <0.001
    28,801–36,300 14,894 94.98 787 5.02 0.54 0.44 0.66 <0.001
    36,301–45,800 10,836 96.10 440 3.90 0.48 0.39 0.59 <0.001
    45,801–57,800 5,824 95.82 254 4.18 0.51 0.40 0.64 <0.001
    ≥57,801 7,238 95.60 333 4.40 0.53 0.42 0.66 <0.001
Charlson Comorbidity Index (CCI) <0.001
    0 (ref.) 68,775 96.18 2,731 3.82 1.00
    1 15,469 94.97 820 5.03 1.28 1.17 1.40 <0.001
    2 7,511 93.83 494 6.17 1.51 1.35 1.69 <0.001
    ≥3 7,193 90.15 786 9.85 2.37 2.14 2.62 <0.001
Major Diagnostic Category(MDC) <0.001
    MDC10 (ref.) 1,843 98.14 35 1.86 1.00
    MDC2 1,103 96.58 39 3.42 1.23 0.77 1.97 0.389
    MDC3 4,141 96.44 153 3.56 1.89 1.30 2.75 <0.001
    MDC5 8,350 93.38 592 6.62 2.49 1.75 3.54 <0.001
    MDC6 14,530 95.06 755 4.94 2.45 1.73 3.47 <0.001
    MDC7 3,525 96.00 147 4.00 1.83 1.25 2.66 0.002
    MDC8 25,063 95.06 1,302 4.94 2.11 1.50 2.98 <0.001
    MDC9 387 97.97 8 2.03 0.95 0.44 2.08 0.901
    MDC11 111 86.05 18 13.95 4.95 2.69 9.10 <0.001
    MDC12 1,332 88.80 168 11.20 4.23 2.88 6.20 <0.001
    MDC13 8,758 97.11 261 2.89 1.65 1.15 2.37 0.006
    MDC14 29,805 95.66 1,353 4.34 2.66 1.88 3.77 <0.001
hospital accreditation level <0.001
    medical center (ref.) 33,886 95.27 1,682 4.73 1.00
    regional hospital 42,799 94.99 2,256 5.01 1.07 0.45 2.51 0.503
    district hospital 22,263 96.14 893 3.86 0.87 0.35 2.19 0.312
hospital ownership <0.001
    public hospital (ref.) 22,813 94.59 1,306 5.41 1.00
    non-public hospital 76,135 95.57 3,525 4.43 0.78 0.70 0.87 <0.001
urbanization of residence area <0.001
    Level 1 (ref.) 28,402 95.59 1,310 4.41 1.00
    Level 2 32,698 95.41 1,574 4.59 1.03 0.95 1.11 0.484
    Level 3 15,673 95.67 709 4.33 0.98 0.89 1.08 0.711
    Level 4 13,267 94.71 741 5.29 1.13 1.02 1.26 0.015
    Level 5 1,797 95.53 84 4.47 0.85 0.67 1.08 0.185
    Level 6 3,539 94.40 210 5.60 1.13 0.97 1.33 0.122
    Level 7 3,572 94.62 203 5.38 1.11 0.95 1.31 0.189
same diagnosis
    No - - 4,408 91.24 - - - -
    Yes - - 423 8.76 - - - -
emergency triage and acuity scale
    Level 1 - - 139 2.88 - - - -
    Level 2 - - 832 17.22 - - - -
    Level 3 - - 2,722 56.34 - - - -
    Level 4 - - 795 16.46 - - - -
    Level 5 - - 115 2.38 - - - -
    unknown - - 228 4.72 - - - -

Note: The hospital is the hospital that DRGs patient discharged from.

Multilevel logistic regression was then used to examine factors associated with ED visits within 14 days (Table 2) and identified age, monthly salary, CCI, MDC, hospital ownership, and urbanization of residence area correlated with visits (p < 0.05). In terms of age, patients ≤ 18 years as the reference group, the number of ED visits within 14 days was higher in patients aged ≥ 65 years old than in the reference group (OR = 1.42, 95% CI: 1.12–1.78). Patients with a monthly salary of ≤ 17,280 NTD as the reference group and the risk of ED visits within 14 days were lower in patients with higher monthly salaries than the reference group (p < 0.05). Patients from generally rural areas (Level 4) have a higher risk of ED visits within 14 days (OR = 1.13, 95% CI: 1.02–1.26). In terms of severity of comorbidities, the results showed that the higher the CCI score, the higher the risk of ED visits within 14 days (p < 0.05).

In terms of MDCs, patients with Endocrine, Nutritional, and Metabolic Diseases and Disorders (MDC10) as the reference group, patients with Diseases and Disorders of the Kidney and Urinary Tract (MDC11) had the highest risk of ED visits within 14 days (OR = 4.95, 95% CI: 2.69–9.10), followed by patients with Diseases and Disorders of the Male Reproductive System (MDC12) (OR = 4.23, 95% CI: 2.88–6.20). The risk of ED visits within 14 days was significantly lower for patients from non-public hospitals than for those from public hospitals (OR = 0.78, 95% CI: 0.70–0.87).

We further examined the time distribution status of ED visits within 14 days after discharge and calculated the interval between discharge and ED visits by subtracting the ED visit date from the discharge date. Fig 1 shows that the proportion of patients with ED visits within one day after discharge was the highest (18.82%), which gradually decreased with the number of days. Within three days of discharge, the proportion of patients with ED visits accounted for 37.57%. Among patients visiting ED, the proportions of patients with ED visits on Day 4 (8.16%) and Day 5 (8.28%) were similar to that on Day 3 (8.92%).

Fig 1. The time distribution of emergency department visits within 14 days after discharge.

Fig 1

Section 2 of the analysis examines whether patients were readmitted to the hospitals within 30 days of discharge. From Table 3, we can see that 7,234 patients were readmitted within 30 days (accounting for 6.97%). Among these patients, 9.28% of patients had the same primary and secondary diagnoses as the previous hospitalization. From the bivariate analysis results in Table 3, we can see that gender, age, monthly salary, CCI, MDCs, hospital accreditation level, and hospital ownership show a significant correlation with readmission within 30 days of discharge (p < 0.05).

Table 3. Bivariate and multilevel regression analysis of DRGs patients’ readmissions within 30 days after discharge.

Variable Total No Yes P value Adjusted OR 95%CI P value
N % N % N %
Total 103,779 100.00 96,545 93.03 7,234 6.97
gender <0.001
    female (ref.) 69,240 66.72 63,832 92.19 5,408 7.81 1.00
    male 34,539 33.28 32,713 94.71 1,826 5.29 1.28 1.18 1.39 <0.001
age (year) <0.001
    ≤18 (ref.) 2,456 2.37 2,397 97.60 59 2.40 1.00
    19–44 51,261 49.39 46,888 91.47 4,373 8.53 1.35 1.02 1.77 0.033
    45–64 26,531 25.56 25,512 96.16 1,019 3.84 1.69 1.29 2.23 <0.001
    ≥65 23,531 22.67 21,748 92.42 1,783 7.58 2.54 1.93 3.35 <0.001
monthly salary (NTD) <0.001
    ≤17,280 (ref.) 1,468 1.41 1,301 88.62 167 11.38 1.00
    17,281–22,800 41,238 39.74 38,425 93.18 2,813 6.82 0.48 0.40 0.57 <0.001
    22,801–28,800 20,467 19.72 19,109 93.36 1,358 6.64 0.48 0.40 0.58 <0.001
    28,801–36,300 15,681 15.11 14,523 92.62 1,158 7.38 0.50 0.42 0.60 <0.001
    36,301–45,800 11,276 10.87 10,508 93.19 768 6.81 0.48 0.40 0.58 <0.001
    45,801–57,800 6,078 5.86 5,605 92.22 473 7.78 0.45 0.37 0.54 <0.001
    ≥57,801 7,571 7.30 7,074 93.44 497 6.56 0.48 0.39 0.58 <0.001
Charlson Comorbidity Index (CCI) <0.001
    0 (ref.) 71,506 68.90 66,726 93.32 4,780 6.68 1.00
    1 16,289 15.70 15,342 94.19 947 5.81 1.19 1.10 1.29 <0.001
    2 8,005 7.71 7,441 92.95 564 7.05 1.58 1.42 1.75 <0.001
    ≥3 7,979 7.69 7,036 88.18 943 11.82 2.62 2.38 2.89 <0.001
Major Diagnostic Category (MDC) <0.001
    MDC10 (ref.) 1,878 1.81 1,855 98.78 23 1.22 1.00
    MDC2 1,142 1.10 1,055 92.38 87 7.62 3.33 2.06 5.37 <0.001
    MDC3 4,294 4.14 4,231 98.53 63 1.47 1.13 0.69 1.84 0.628
    MDC5 8,942 8.62 8,093 90.51 849 9.49 4.45 2.91 6.82 <0.001
    MDC6 15,285 14.73 14,839 97.08 446 2.92 1.87 1.22 2.87 0.004
    MDC7 3,672 3.54 3,555 96.81 117 3.19 1.98 1.26 3.13 0.003
    MDC8 26,365 25.40 24,984 94.76 1,381 5.24 3.05 2.00 4.66 <0.001
    MDC9 395 0.38 351 88.86 44 11.14 9.53 5.62 16.13 <0.001
MDC11 129 0.12 116 89.92 13 10.08 3.98 1.93 8.20 <0.001
    MDC12 1,500 1.45 1,397 93.13 103 6.87 2.52 1.58 4.04 <0.001
    MDC13 9,019 8.69 8,875 98.40 144 1.60 1.64 1.04 2.57 0.032
    MDC14 31,158 30.02 27,194 87.28 3,964 12.72 20.43 13.32 31.34 <0.001
hospital accreditation level <0.001
    medical center (ref.) 35,568 34.27 33,425 93.97 2,143 6.03 1.00
    regional hospital 45,055 43.41 41,379 91.84 3,676 8.16 1.25 0.23 6.69 0.339
    district hospital 23,156 22.31 21,741 93.89 1,415 6.11 0.87 0.17 4.59 0.485
hospital ownership 0.036
    public hospital (ref.) 24,119 23.24 22,511 93.33 1,608 6.67 1.00
    non-public hospital 79,660 76.76 74,034 92.94 5,626 7.06 0.80 0.67 0.96 0.019
urbanization of residence area 0.147
    Level 1 (ref.) 29,712 28.63 27,666 93.11 2,046 6.89 1.00
    Level 2 34,272 33.02 31,887 93.04 2,385 6.96 0.99 0.93 1.06 0.855
    Level 3 16,382 15.79 15,292 93.35 1,090 6.65 1.02 0.94 1.11 0.683
    Level 4 14,008 13.50 13,009 92.87 999 7.13 1.01 0.92 1.11 0.828
    Level 5 1,881 1.81 1,745 92.77 136 7.23 1.15 0.94 1.39 0.168
    Level 6 3,749 3.61 3,460 92.29 289 7.71 1.14 0.99 1.32 0.073
    Level 7 3,775 3.64 3,486 92.34 289 7.66 1.11 0.96 1.28 0.172
readmission with same diagnosis
    No 6,563 90.72 - - - -
    Yes 671 9.28 - - - -

Note: The hospital was the hospital that DRGs patients discharged from.

We employed multilevel logistic regression to examine factors associated with readmission within 30 days (Table 3). The results show that gender, age, monthly salary, CCI, MDCs, and hospital ownership showed significant correlations with readmission within 30 days of discharge (p < 0.05). In terms of gender, the risk of male patients being readmitted within 30 days of discharge was significantly higher than in female patients (OR = 1.28, 95% CI: 1.18–1.39). Patients ≤ 18 years used as the reference group. The patients who were older than the reference group had a significantly higher risk of readmission within 30 days (p < 0.05), and the risk of readmission within 30 days increased with age. In terms of monthly salary, patients with a monthly salary of ≤ 17,280 NTD taken as the reference group, the risk of readmission within 30 days is significantly lower in patients with higher monthly salaries than the reference group (p < 0.05). In terms of severity of comorbidities, results showed that the higher the CCI score, the higher the risk of readmission within 30 days (p < 0.05). In terms of MDCs, patients with Endocrine, Nutritional, and Metabolic Diseases and Disorders (MDC10) used as the reference group, as they had the lowest proportion of readmission within 30 days, results showed that patients with Pregnancy, Childbirth, and the Puerperium (MDC14) had the highest risk of readmission within 30 days (OR = 20.43, 95%CI: 13.32–31.34), followed by patients with Diseases and Disorders of the Skin, Subcutaneous Tissue, and Breast (MDC9) (OR = 9.53, 95% CI: 5.62–16.13). Public hospitals taken as the reference group, patients from non-public hospitals had a significantly lower risk of readmission within 30 days (OR = 0.80, 95%CI:0.67–0.96).

We further examined the time distribution of readmission within 30 days of discharge and calculated the interval between discharge and readmission by subtracting the readmission date from the discharge date. From Fig 2, we can see that the proportion of patients with readmission within one day after discharge was the highest (26.38%), which gradually decreased with the number of days. Within 14 days of discharge, the proportion of patients with readmission accounted for 75.05%.

Fig 2. The time distribution of readmission within 30 days after discharge.

Fig 2

Section 3 of the analysis examined patients who underwent hospital transfers. From Table 4, we can see that out of 103,779 inpatients, only 169 inpatients transferred hospitals (accounting for 0.16%). From the bivariate analysis in Table 4, we can see that gender, age, urbanization of residence area, urbanization of the hospital’s location, CCI, MDCs, hospital accreditation level, number of hospital beds, and route of hospitalization were significantly correlated with whether patients underwent hospital transfers (p < 0.05).

Table 4. Bivariate and multilevel regression analysis of DRGs patients’ hospital transfer.

Variable Total No Yes P value Adjusted OR 95%CI P value
N % N % N %
Total 103,779 100.00 103,610 99.84 169 0.16
gender 0.030
    female (ref.) 69,240 66.72 69,141 99.86 99 0.14 1.00
    male 34,539 33.28 34,469 99.80 70 0.20 1.74 1.13 2.70 0.013
age (year) 0.011
    ≤18 (ref.) 2,456 2.37 2,455 99.96 1 0.04 1.00
    19–44 51,261 49.39 51,184 99.85 77 0.15 2.37 0.31 17.91 0.402
    45–64 26,531 25.56 26,495 99.86 36 0.14 2.23 0.30 16.81 0.435
    ≥65 23,531 22.67 23,476 99.77 55 0.23 2.55 0.34 19.24 0.365
monthly salary (NTD) 0.818
    ≤17,280 (ref.) 1,468 1.41 1,466 99.86 2 0.14 1.00
    17,281–22,800 41,238 39.74 41,173 99.84 65 0.16 1.20 0.29 4.98 0.801
    22,801–28,800 20,467 19.72 20,429 99.81 38 0.19 1.67 0.40 7.04 0.482
    28,801–36,300 15,681 15.11 15,653 99.82 28 0.18 1.44 0.34 6.14 0.626
    36,301–45,800 11,276 10.87 11,256 99.82 20 0.18 1.84 0.42 8.03 0.416
    45,801–57,800 6,078 5.86 6,071 99.88 7 0.12 1.17 0.24 5.75 0.848
    ≥57,801 7,571 7.30 7,562 99.88 9 0.12 1.41 0.30 6.66 0.664
Charlson Comorbidity Index (CCI) <0.001
    0 (ref.) 71,506 68.90 71,420 99.88 86 0.12 1.00
    1 16,289 15.70 16,261 99.83 28 0.17 1.55 0.95 2.51 0.077
    2 8,005 7.71 7,979 99.68 26 0.32 2.88 1.68 4.96 <0.001
    ≥3 7,979 7.69 7,950 99.64 29 0.36 2.45 1.40 4.30 0.002
Major Diagnostic Category (MDC) <0.001
    MDC13 (ref.) 9,019 8.69 9,017 99.98 2 0.02 1.00
    MDC2 1,142 1.10 1,141 99.91 1 0.09 - - - -
    MDC3 4,294 4.14 4,294 100.00 0 0.00 - - - -
    MDC5 8,942 8.62 8,893 99.45 49 0.55 9.51 2.09 43.19 0.004
    MDC6 15,285 14.73 15,279 99.96 6 0.04 0.60 0.11 3.13 0.540
    MDC7 3,672 3.54 3,669 99.92 3 0.08 1.48 0.24 9.26 0.676
    MDC8 26,365 25.40 26,321 99.83 44 0.17 1.95 0.44 8.66 0.377
    MDC9 395 0.38 395 100.00 0 0.00 - - - -
    MDC10 1,878 1.81 1,878 100.00 0 0.00 - - - -
    MDC11 129 0.12 129 100.00 0 0.00 - - - -
    MDC12 1,500 1.45 1,499 99.93 1 0.07 - - - -
    MDC14 31,158 30.02 31,095 99.80 63 0.20 5.61 1.32 23.83 0.020
whether through the ED or not <0.001
    No (ref.) 77,690 74.86 77,594 99.88 96 0.12 1.00
    Yes 26,089 25.14 26,016 99.72 73 0.28 2.42 1.73 3.39 <0.001
hospital accreditation level <0.001
    medical center (ref.) 35,496 34.20 35,478 99.95 18 0.05 1.00
    regional hospital 45,089 43.45 44,993 99.79 96 0.21 1.94 0.01 543.05 0.375
    district hospital 23,194 22.35 23,139 99.76 55 0.24 1.13 0.00 3342.59 0.874
hospital ownership 0.892
    public hospital (ref.) 24,099 23.22 24,061 99.84 38 0.16 1.00
    non-public hospital 79,680 76.78 79,549 99.84 131 0.16 0.86 0.52 1.42 0.547
number of hospital beds <0.001
    ≤300 beds (ref.) 18,692 18.01 18,645 99.75 47 0.25 1.00
    301–600 beds 17,171 16.55 17,118 99.69 53 0.31 0.51 0.17 1.47 0.174
    601–1,000 beds 23,081 22.24 23,040 99.82 41 0.18 0.25 0.07 0.88 0.035
    1,001–1,500 beds 23,553 22.70 23,533 99.92 20 0.08 0.15 0.04 0.60 0.014
    ≥1,501 beds 21,282 20.51 21,274 99.96 8 0.04 0.09 0.01 0.58 0.018
urbanization of residence area <0.001
    Level 1 (ref.) 29,712 28.63 29,683 99.90 29 0.10 1.00
    Level 2 34,272 33.02 34,204 99.80 68 0.20 1.44 0.90 2.30 0.123
    Level 3 16,382 15.79 16,365 99.90 17 0.10 0.83 0.44 1.55 0.556
    Level 4 14,008 13.50 13,972 99.74 36 0.26 1.64 0.94 2.85 0.080
    Level 5 1,881 1.81 1,876 99.73 5 0.27 1.94 0.70 5.33 0.200
    Level 6 3,749 3.61 3,743 99.84 6 0.16 1.15 0.45 2.93 0.771
    Level 7 3,775 3.64 3,767 99.79 8 0.21 1.30 0.56 3.03 0.544
urbanization of hospital’s location <0.001
    Level 1 (ref.) 33,833 32.60 33,809 99.93 24 0.07 1.00
    Level 2 49,153 47.36 49,054 99.80 99 0.20 1.77 0.98 3.20 0.059
    Level 3 8,154 7.86 8,141 99.84 13 0.16 1.48 0.63 3.46 0.363
    Level 4 11,474 11.06 11,442 99.72 32 0.28 1.71 0.83 3.54 0.146
    Level 5–7 1,165 1.12 1,164 99.91 1 0.09 0.50 0.06 4.22 0.519

Note: The hospital was the hospital that DRGs patient discharged from. Logistic regression model did not include MDC2, MDC3, MDC9, MDC10, MDC11, and MDC12 patients.

We employed multilevel logistic regression to examine factors associated with hospital transfers (Table 4). Results showed that gender, CCI, MDCs, number of hospital beds, and hospitalization route showed significant correlations with hospital transfers (p < 0.05). Regarding gender, the risk of hospital transfer in male patients was significantly higher than in female patients (OR = 1.74, 95%CI: 1.13–2.70). In terms of severity of comorbidities, patients with a CCI score of 2 points (OR = 2.88, 95%CI: 1.68–4.96) or ≥ 3 points (OR = 2.45, 95%CI: 1.40–4.30) had the highest risk of hospital transfers. Concerning MDCs, disease categories without hospital transfers (MDC 2, 3, 9, 10, 11, and 12) were excluded. Patients with Diseases and Disorders of the Circulatory System (MDC5) had the highest risk of hospital transfer (OR = 9.51, 95% CI: 2.09–43.19), followed by patients with Pregnancy, Childbirth, and the Puerperium (MDC14) (OR = 5.61, 95%CI: 1.32–23.83). In terms of the number of hospital beds, patients from hospitals with ≥ 601 beds had a significantly lower risk of hospital transfer (p < 0.05), and overall patients from hospitals with ≥ 1501 beds had the lowest risk of hospital transfer (OR = 0.09, 95%CI: 0.01–0.58). In terms of route of hospitalization, patients who were admitted through the ED had a significantly higher risk of hospital transfer (OR = 2.36, 95%CI: 1.71–3.27).

4. Discussion

This study examined the patient characteristics of ED visits within 14 days and the relevant factors for such patients under the DRG-based payment system. Concerning patient characteristics, the results in Table 2 show that patients ≥ 65 years old had the highest risk of ED visits within 14 days. It may be because elderly patients are prone to careless falls [40], poor health status, or chronic diseases, which increase the rate of ED visits. Our study showed that patients with a higher monthly salary had a lower risk of ED visits within 14 days. A previous US study examined patients who underwent septorhinoplasty [20]. The results showed that patients with lower socioeconomic status had a higher risk of ED visits within 30 days [20], which is similar to the results of this study. Turning to the severity of comorbidities, the results of this study showed that the risk of ED visits within 14 days increased as the CC1 score of patients increased, of whom patients with CCI ≥ 3 points had the highest risk of ED visits within 14 days. It is consistent with the results of a previous US study that examined the risk of ED visits within three days, seven days, 30 days, and one year in patients aged ≥ 65. The results showed that the higher the CCI score of the patient, the higher the risk of ED visits [40].

About disease diagnosis categories, the results of this study showed that patients with Diseases and Disorders of the Kidney and Urinary Tract (MDC11) had the highest risk of ED visits within 14 days, followed by patients with Diseases and Disorders of the Male Reproductive System (MDC12). A previous study in Taiwan examined patients who had ED visits within three days and showed that patients with diseases of the digestive system accounted for most patients with ED visits [41], which is not consistent with the results of this study. This discrepancy in reporting could be because Diseases and Disorders of the Digestive System (MDC6) in our study included only surgical patients. In contrast, the study subjects in that paper included internal medicine and surgical patients, resulting in differences in the proportion of patients in disease categories. The results of this study show that among patients who had ED visits within 14 days, most patients had a triage grade of 3 (accounting for 56.34%), while the proportion of patients with triage grades 4 and 5 (18.84%) was similar to that of patients with grades 1 and 2 (20.1%). This result is similar to that of a Canadian study that found that patients with ED visits are mostly less urgent patients and not urgent ones [42].

With regard to the risk of readmission within 30 days of discharge, the results of this study show that male patients had a significantly higher risk than female patients. It is similar to the findings of the previous study in the US of patients with inflammatory bowel disease that examined the characteristics of patients who were readmitted within 30 days [43]. It showed that the risk of readmission within 30 days was higher in males than in female patients [43]. With regard to age, the results of this study showed that patients aged ≥ 65 years old had the highest risk of readmission within 30 days. A previous US study examined the revisit rate (including readmission rate for outpatient procedures, readmission rate, or ED revisit) in patients who underwent septorhinoplasty [20]. Results showed that patients aged ≥ 65 years old had a higher risk of hospital revisit rate [20], which is similar to the results of this study. Concerning monthly salaries, the results of this study showed that patients with higher monthly salaries had a lower risk of readmission within 30 days. A study of patients with inflammatory bowel disease examined the characteristics of patients who were readmitted within 30 days [43] and found that patients with a higher mean income had a lower risk of readmission than patients with a lower mean income is similar to the results of this study.

Concerning the severity of comorbidities, the results of this study showed that patients with CCI ≥ 3 points had the highest risk of readmission within 30 days. A previous US study of patients who underwent colectomy showed that patients with CCI ≥ 2 points had a significantly higher risk of readmission within 30 days [17], which is similar to the results of this study. About disease diagnosis categories, our study found that patients with Pregnancy, Childbirth, and the Puerperium (MDC14) had the highest risk of readmission within 30 days. It may be because pregnancy, childbirth, and puerperium are unstable periods, and patients may be hospitalized for short periods for delivery. Therefore, MDC14 patients have a higher risk of readmission than do patients in other disease diagnosis categories. However, previous studies found that under the DRG-based payment system, the risk of readmission within 30 days in patients who underwent specific obstetric and gynecological surgeries (cesarean section, hysterectomy, etc.) showed a decreasing trend [44]. A previous study in France examined the risk of readmission within 30 days and the trends in patients from different MDCs before and after implementing a DRG-based payment system [45]. They found that as time progressed, ophthalmology gradually became the disease category with the highest risk of readmission within 30 days, while obstetric and gynecological diseases also had a higher risk of readmission within 30 days than other disease categories [45]. Our study also found that patients with Diseases and Disorders of the Skin, Subcutaneous Tissue, and Breast (MDC9) had the second-highest risk of readmission within 30 days. We conducted further analyses and found that a primary reason was that the unilateral total or subtotal mastectomy for carcinoma in situ of the breast without complication and comorbidity had a higher readmission rate. A previous study showed a high rate of incomplete resection in extensive ductal carcinoma in situ (DCIS) of breast cancer, which led to readmission for surgery [46].

In Taiwan, in order to prevent doctors’ dividing up DRG-based hospital stays for seeking health insurance reimbursement, the NHI monitored readmissions and would not reimburse for the second admission within 14 days after discharge. From Fig 2, which shows the time distribution of readmission within 30 days of discharge, we can see that patients admitted within 14 days after discharge accounted for 75.03% of all readmissions. A small increase in the number of patients readmitted on day 15 (1.77%) was not significantly different from those who had a readmission on day 14 (1.63%). Thus, from this study, it was not apparent that healthcare providers displayed rule avoidance and advantage-taking behaviors as has been mentioned in previous literature as occurring when DRG-based payment systems were implemented in some countries [2931].

There has been no study examining the relevant factors for hospital transfer in patients under the DRG-based payment system, and our study can be considered the first paper to do so. The results of this study's analysis show that the risk of hospital transfer in male patients is significantly higher than that of female patients. A previous US study of the relevant factors for hospital transfer in hospitalized patients across the US showed that male patients have a higher risk of hospital transfer than female patients [25], which is similar to the results of this study. It may be because of innate differences in the risk of developing diseases between males and females [47]. We further conducted stratification analyses according to gender among patients who were transferred to other hospitals and found that among this group, male patients were more likely to be older than 45 years (68.14% vs 39.62%) with a higher Charlson comorbidity index as compared to their female counterparts. Besides, 32.68% of male patients were diagnosed with MDC8, which had a higher hospital transfer rate, whereas 21.77% of female patients diagnosed with this category of disease. It is why male patients had a higher risk of hospital transfer than in female patients.

With regard to the severity of comorbidities, the results of this study showed that patients with CCI ≥ 3 points had a higher risk of hospital transfer. A study of patients ≥ 65 years old examined their risk of hospital transfer and showed that patients with higher CCI had a higher risk of hospital transfer [48]. Concerning MDCs, no previous study has compared the correlation between MDCs and the risk of hospital transfer. This study shows that patients with Diseases and Disorders of the Circulatory System (MDC5) had the highest risk of a hospital transfer, followed by patients with Pregnancy, Childbirth, and the Puerperium (MDC14). It is because patients with MDC5 may be emergency patients, and immediate hospital transfer for treatment is required if the hospital is unable to treat the patient immediately, resulting in these patients having a higher risk of hospital transfer than those in other categories. On the other hand, due to emergency, MDC14 patients may be admitted for surgeries to neighboring hospitals that are not those they usually visit for a consultation. Therefore, this may cause patients to transfer to other hospitals after delivery, resulting in a higher risk of hospital transfer.

Moreover, there was no study in the past, examining the correlation between hospital beds and the risk of hospital transfer. Our analysis results showed that patients from hospitals with ≥ 601 beds had a significantly lower risk of a hospital transfer. Patients from hospitals with ≥ 1501 beds had the lowest risk of hospital transfer. This phenomenon is consistent with general reasoning: As the number of beds increases, the hospital has a higher capacity to treat patients. The rate of hospital transfer is relatively lower. Therefore, it can be observed that the risk of hospital transfer decreases as the number of beds increases. About the route of hospitalization, few studies have examined whether the risk of hospital transfer is related to admission through the ED. The results of this study show that patients who were admitted through the ED had a higher risk of hospital transfer. It may be because the hospital where a patient was admitted through the ED for hospitalization and treatment was not the hospital where the patient usually seeks consultation. It results in a higher risk to the patient of hospital transfer during hospitalization.

5. Limitations

Our study was unable to accurately compare the case payment classification method that was implemented before the DRG-based payment system and the classification methods in the DRG-based payment system. Therefore, we were unable to examine the differences before and after implementing the DRG-based payment system. Besides, we found from our literature review that many factors are associated with readmission or ED visits. However, some data can only be obtained from questionnaire surveys. As our study is an analysis of the NHIRD, we were unable to include all possible factors for a complete examination. Concerning the readmission of study subjects, we were unable to distinguish between planned and unplanned readmissions. Therefore, we were unable to examine patients with unplanned readmissions independently. During the literature review, we found that physician availability is one of the critical factors for ED visits or readmissions by patients. However, as the limited physician data in the NHIRD, we, therefore, did not include physician factors in this study. Finally, since our patients were mainly surgical patients, the study findings cannot be generalized to medical admissions.

6. Conclusions

Our study found that under the DRG-based payment system, MDCs are important correlation factors for ED visits within 14 days, readmission within 30 days, or hospital transfers. This study showed that patients with Diseases and Disorders of the Kidney and Urinary Tract (MDC11) had the highest risk of ED visits within 14 days, followed by patients with Diseases and Disorders of the Male Reproductive System (MDC12). About the risk of readmission within 30 days, patients with Pregnancy, Childbirth, and the Puerperium (MDC14) had the highest risk, followed by patients with Diseases and Disorders of the Skin, Subcutaneous Tissue, and Breast (MDC9). Concerning hospital transfer, patients with Diseases and Disorders of the Circulatory System (MDC5) had the highest risk of hospital transfers, followed by patients with Pregnancy, Childbirth, and the Puerperium (MDC14). We recommend further investigation into the possible reasons for the higher risk of ED visits, readmission, and hospital transfers for patients in the MDCs that have a higher risk of such actions. Finally, we did not find healthcare providers had significant rule avoidance and advantage-taking behaviors, in which hospitals may delay readmission by 1 to 3 days to avoid the 14-day readmission indicator.

Acknowledgments

We are grateful to Health Data Science Center, China Medical University Hospital for providing administrative and technical support.

List of abbreviations

DRGs

Diagnosis Related Groups

MDC

Major Diagnostic Category

NHI

National Health Insurance

NHIRD

National Health Insurance Research Database

ICD-9-CM

International Classification of Diseases, Ninth Revision, Clinical Modification

CCI

Charlson Comorbidity Index

ED

Emergency department

OR

odds ratio

CI

confidence interval

PPS

Prospective payment system

NTD

New Taiwan dollar

IRB

institution review board

SSTI

skin and soft tissue infection

Data Availability

Regarding the data availability, data were obtained from the National Health Insurance Research Database published by the Ministry of Health and Welfare, Taiwan. Due to legal restrictions imposed by the Taiwan government related to the Personal Information Protection Act, the database cannot be made publicly available. All researchers can apply for using the databases to conduct their studies. Requests for data can be sent as a formal proposal to the Health and Welfare Data Science Center of the Ministry of Health and Welfare (email: stpeicih@mohw.gov.tw; https://www.mohw.gov.tw/cp-114-246-2.html). Any raw data are not allowed to be brought out from the Health and Welfare Data Science Center. The restrictions prohibited the authors from making the minimal data set publicly available.

Funding Statement

This study was supported by the grants (grant numbers DOH102-NH-9009; DMR-109-189) from the National Health Insurance Administration, Taiwan, Asia University and China Medical University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Stern RS, Epstein AM. Institutional responses to prospective payment based on diagnosis-related groups. Implications for cost, quality, and access. The New England journal of medicine. 1985;312(10):621–7. Epub 1985/03/07. 10.1056/NEJM198503073121005 . [DOI] [PubMed] [Google Scholar]
  • 2.Moreno-Serra R, Wagstaff A. System-wide impacts of hospital payment reforms: evidence from Central and Eastern Europe and Central Asia. Journal of health economics. 2010;29(4):585–602. Epub 2010/06/23. 10.1016/j.jhealeco.2010.05.007 . [DOI] [PubMed] [Google Scholar]
  • 3.Schargus M, Gass P, Neubauer A, Kotas M. Development of the German diagnosis-related groups (G-DRG) for ophthalmology from 2004 to 2012. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2014;111(4):354–64. Epub 2013/06/20. 10.1007/s00347-013-2886-y . [DOI] [PubMed] [Google Scholar]
  • 4.Jang SI, Nam CM, Lee SG, Kim TH, Park S, Park EC. Impact of payment system change from per-case to per-diem on high severity patient's length of stay. Medicine. 2016;95(37). 10.1097/MD.0000000000004839 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wang K, Li P, Chen L, Kato K, Kobayashi M, Yamauchi K. Impact of the Japanese diagnosis procedure combination-based payment system in Japan. Journal of medical systems. 2010;34(1):95–100. Epub 2010/03/03. 10.1007/s10916-008-9220-2 . [DOI] [PubMed] [Google Scholar]
  • 6.Latta VB, Helbing C. Medicare: short-stay hospital services, by leading diagnosis-related groups, 1983 and 1985. Health care financing review. 1988;10(2):79–107. Epub 1988/12/05. [PMC free article] [PubMed] [Google Scholar]
  • 7.Cheng SH, Chen CC, Tsai SL. The impacts of DRG-based payments on health care provider behaviors under a universal coverage system: a population-based study. Health policy (Amsterdam, Netherlands). 2012;107(2–3):202–8. Epub 2012/04/27. 10.1016/j.healthpol.2012.03.021 . [DOI] [PubMed] [Google Scholar]
  • 8.Kim H, Jung IM, Yun KW, Heo SC, Ahn YJ, Hwang K-T, et al. Early outcome of the Korean Diagnosis-Related Groups payment system for appendectomy. Ann Surg Treat Res. 2015;88(3):126–32. 10.4174/astr.2015.88.3.126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Moon SB. Early results of pediatric appendicitis after adoption of diagnosis-related group-based payment system in South Korea. Journal of Multidisciplinary Healthcare. 2015;8:503–9. 10.2147/JMDH.S95937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Mihailovic N, Kocic S, Jakovljevic M. Review of Diagnosis-Related Group-Based Financing of Hospital Care. Health services research and managerial epidemiology. 2016;3:2333392816647892 Epub 2017/05/04. 10.1177/2333392816647892 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ishii M. DRG/PPS and DPC/PDPS as Prospective Payment Systems. Japan Medical Association journal: JMAJ. 2012;55(4):279–91. Epub 2012/07/01. . [PubMed] [Google Scholar]
  • 12.Hamada H, Sekimoto M, Imanaka Y. Effects of the per diem prospective payment system with DRG-like grouping system (DPC/PDPS) on resource usage and healthcare quality in Japan. Health policy (Amsterdam, Netherlands). 2012;107(2–3):194–201. Epub 2012/01/27. 10.1016/j.healthpol.2012.01.002 . [DOI] [PubMed] [Google Scholar]
  • 13.Forgione DA, Vermeer TE, Surysekar K, Wrieden JA, Plante CA. The impact of DRG-based payment systems on quality of health care in OECD countries. Journal of health care finance. 2004;31(1):41–54. Epub 2005/04/09. . [PubMed] [Google Scholar]
  • 14.Ljunggren B, Sjödén PO. Patient reported quality of care before vs. after the implementation of a diagnosis related groups (DRG) classification and payment system in one Swedish county. Scandinavian Journal of Caring Sciences. 2001;15(4):283–94. 10.1046/j.1471-6712.2001.00046.x [DOI] [PubMed] [Google Scholar]
  • 15.Busato A, von Below G. The implementation of DRG-based hospital reimbursement in Switzerland: A population-based perspective. Health research policy and systems. 2010;8:31 Epub 2010/10/19. 10.1186/1478-4505-8-31 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.National Health Insurance Administration, Ministry of Health and Welfare. National Health Insurance Annual Report (2016–2017) Accessed June 14, 2017. Available from: https://www.nhi.gov.tw/Content_List.aspx?n=F02F2F627FE4BEC4&topn=CDA985A80C0DE710.
  • 17.Kulaylat AN, Dillon PW, Hollenbeak CS, Stewart DB. Determinants of 30-d readmission after colectomy. The Journal of surgical research. 2015;193(2):528–35. Epub 2014/12/03. 10.1016/j.jss.2014.09.029 . [DOI] [PubMed] [Google Scholar]
  • 18.Rubin DJ. Hospital readmission of patients with diabetes. Current diabetes reports. 2015;15(4):17 Epub 2015/02/26. 10.1007/s11892-015-0584-7 . [DOI] [PubMed] [Google Scholar]
  • 19.Ansari SF, Yan H, Zou J, Worth RM, Barbaro NM. Hospital Length of Stay and Readmission Rate for Neurosurgical Patients. Neurosurgery. 2017. Epub 2017/04/13. 10.1093/neuros/nyx160 . [DOI] [PubMed] [Google Scholar]
  • 20.Spataro E, Branham GH, Kallogjeri D, Piccirillo JF, Desai SC. Thirty-Day Hospital Revisit Rates and Factors Associated With Revisits in Patients Undergoing Septorhinoplasty. JAMA facial plastic surgery. 2016;18(6):420–8. 10.1001/jamafacial.2016.0539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang KC, Chaou CH, Liu PH, Chien CY, Lee CH. Factors Affecting Unscheduled Return Visits to the Emergency Department among Minor Head Injury Patients. BioMed Research International. 2017;2017:8963102 Epub 2017/10/12. 10.1155/2017/8963102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Doherty P, Digby B. Analysis of critical incidents during the interhospital transport of critically ill patients: Crit Care. 2007;11(Suppl 2):P502 Epub 2007 Mar 22 10.1186/cc5662; 2007. [DOI] [Google Scholar]
  • 23.Odetola FO, Clark SJ, Gurney JG, Donohue JE, Gebremariam A, Allerton L, et al. Factors Associated with Inter-hospital Transfer of Children in Respiratory Failure from Level II to Level I Pediatric Intensive Care Units. Journal of critical care. 2015;30(5):1080–4. 10.1016/j.jcrc.2015.06.008 PMC4681687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Westfall JM, Kiefe CI, Weissman NW, Goudie A, Centor RM, Williams OD, et al. Does interhospital transfer improve outcome of acute myocardial infarction? A propensity score analysis from the Cardiovascular Cooperative Project. BMC Cardiovascular Disorders. 2008;8:22 10.1186/1471-2261-8-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Hernandez-Boussard T, Davies S, McDonald K, Wang NE. Interhospital Facility Transfers in the United States: A Nationwide Outcomes Study. Journal of patient safety. 2017;13(4):187–91. 10.1097/PTS.0000000000000148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hensen P, Beissert S, Bruckner-Tuderman L, Luger TA, Roeder N, Müller ML. Introduction of diagnosis-related groups in Germany: evaluation of impact on in-patient care in a dermatological setting. European Journal of Public Health. 2008;18(1):85–91. 10.1093/eurpub/ckm059 [DOI] [PubMed] [Google Scholar]
  • 27.Kim SJ, Han KT, Kim SJ, Park EC, Park HK. Impact of a diagnosis-related group payment system on cesarean section in Korea. Health policy (Amsterdam, Netherlands). 2016;120(6):596–603. Epub 2016/05/14. 10.1016/j.healthpol.2016.04.018 . [DOI] [PubMed] [Google Scholar]
  • 28.Hu WY, Yeh CF, Shiao AS, Tu TY. Effects of diagnosis-related group payment on health-care provider behaviors: A consecutive three-period study. Journal of the Chinese Medical Association: JCMA. 2015;78(11):678–85. Epub 2015/09/06. 10.1016/j.jcma.2015.06.012 . [DOI] [PubMed] [Google Scholar]
  • 29.Berta P, Callea G, Martini G, Vittadini G. The effects of upcoding, cream skimming and readmissions on the Italian hospitals efficiency: a population-based investigation. Economic Modelling. 2010;27(4):812–21. [Google Scholar]
  • 30.Jurges H, Koberlein J. What explains DRG upcoding in neonatology? The roles of financial incentives and infant health. Journal of health economics. 2015;43:13–26. Epub 2015/06/27. 10.1016/j.jhealeco.2015.06.001 . [DOI] [PubMed] [Google Scholar]
  • 31.Radu CP, Chiriac DN, Vladescu C. Changing Patient Classification System for Hospital Reimbursement in Romania. Croatian Medical Journal. 2010;51(3):250–8. 10.3325/cmj.2010.51.250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Nakamura K. Development of the reimbursement system based on DPC. Rinsho byori The Japanese journal of clinical pathology. 2004;52(11):906–14. Epub 2005/01/22. . [PubMed] [Google Scholar]
  • 33.Gaughan J, Kobel C. Coronary artery bypass grafts and diagnosis related groups: patient classification and hospital reimbursement in 10 European countries. Health Economics Review. 2014;4:4 10.1186/s13561-014-0004-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Jacobs VR, Rasche L, Harbeck N, Warm M, Mallmann P. Underfinancing of 90.3% for implant costs of prostheses and expanders in DRG revenues for uni- and bilateral mastectomy with immediate breast reconstruction. Onkologie. 2010;33(11):584–8. Epub 2010/10/27. 10.1159/000321144 . [DOI] [PubMed] [Google Scholar]
  • 35.Lotter O, Stahl S, Beck M, Loewe W, Schaller HE. Development of diagnosis-related groups in different surgical disciplines. Zentralblatt fur Chirurgie. 2014;139 Suppl 2:e109–15. Epub 2011/06/21. 10.1055/s-0031-1271532 . [DOI] [PubMed] [Google Scholar]
  • 36.Kim SJ, Han KT, Kim W, Kim SJ, Park EC. Early Impact on Outpatients of Mandatory Adoption of the Diagnosis-Related Group-Based Reimbursement System in Korea on Use of Outpatient Care: Differences in Medical Utilization and Presurgery Examination. Health services research. 2017. Epub 2017/08/15. 10.1111/1475-6773.12749 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Chieh-Yu L, Yunh-Tai H, Yi-Li C, Yi-Ju C, Wen-Shun W, Jih-Shin L, et al. Incorporating Development Stratification of Taiwan Townships into Sampling Design of Large Scale Health Interview Survey. Journal of Health Management. 2006;4(1):1–22. [Google Scholar]
  • 38.Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of clinical epidemiology. 1992;45(6):613–9. 10.1016/0895-4356(92)90133-8 [DOI] [PubMed] [Google Scholar]
  • 39.Ministry of Health and Welfare. Taiwan Triage and Acuity Scale. 2015.
  • 40.Liu SW, Obermeyer Z, Chang Y, Shankar KN. Frequency of ED revisits and death among older adults after a fall. The American journal of emergency medicine. 2015;33(8):1012–8. Epub 2015/05/20. 10.1016/j.ajem.2015.04.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Wang HY, Chew G, Kung CT, Chung KJ, Lee WH. The use of Charlson comorbidity index for patients revisiting the emergency department within 72 hours. Chang Gung medical journal. 2007;30(5):437–44. Epub 2007/12/08. . [PubMed] [Google Scholar]
  • 42.Foran A, Wuerth-Sarvis B, Milne WK. Bounce-back visits in a rural emergency department. Canadian journal of rural medicine: the official journal of the Society of Rural Physicians of Canada = Journal canadien de la medecine rurale: le journal officiel de la Societe de medecine rurale du Canada. 2010;15(3):108–12. Epub 2010/07/08. . [PubMed] [Google Scholar]
  • 43.Micic D, Gaetano JN, Rubin JN, Cohen RD, Sakuraba A, Rubin DT, et al. Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease. PLoS ONE. 2017;12(8):e0182900 10.1371/journal.pone.0182900 PMC5570509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Jung YW, Pak H, Lee I, Kim EH. The Effect of Diagnosis-Related Group Payment System on Quality of Care in the Field of Obstetrics and Gynecology among Korean Tertiary Hospitals. Yonsei medical journal. 2018;59(4):539–45. Epub 2018/05/12. 10.3349/ymj.2018.59.4.539 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Vuagnat A, Yilmaz E, Roussot A, Rodwin V, Gadreau M, Bernard A, et al. Did case-based payment influence surgical readmission rates in France? A retrospective study. BMJ open. 2018;8(2):e018164 Epub 2018/02/03. 10.1136/bmjopen-2017-018164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Knuttel FM, van der Velden BH, Loo CE, Elias SG, Wesseling J, van den Bosch MA, et al. Prediction Model For Extensive Ductal Carcinoma In Situ Around Early-Stage Invasive Breast Cancer. Investigative radiology. 2016;51(7):462–8. Epub 2016/02/11. 10.1097/RLI.0000000000000255 . [DOI] [PubMed] [Google Scholar]
  • 47.Intapad S, Ojeda NB, Dasinger JH, Alexander BT. Sex Differences in the Developmental Origins of Cardiovascular Disease. Physiology. 2014;29(2):122–32. 10.1152/physiol.00045.2013 PMC3949204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Mueller SK, Zheng J, Orav EJ, Schnipper JL. Rates, Predictors and Variability of Interhospital Transfers: A National Evaluation. Journal of hospital medicine. 2017;12(6):435–42. Epub 2017/06/03. 10.12788/jhm.2747 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Regarding the data availability, data were obtained from the National Health Insurance Research Database published by the Ministry of Health and Welfare, Taiwan. Due to legal restrictions imposed by the Taiwan government related to the Personal Information Protection Act, the database cannot be made publicly available. All researchers can apply for using the databases to conduct their studies. Requests for data can be sent as a formal proposal to the Health and Welfare Data Science Center of the Ministry of Health and Welfare (email: stpeicih@mohw.gov.tw; https://www.mohw.gov.tw/cp-114-246-2.html). Any raw data are not allowed to be brought out from the Health and Welfare Data Science Center. The restrictions prohibited the authors from making the minimal data set publicly available.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES